Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Heliyon ; 9(9): e19625, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37809795

ABSTRACT

One of the major causes of blindness in human beings is the diabetic retinopathy (DR). To prevent blindness, early detection of DR is therefore necessary. In this paper, a hybrid model is proposed for diagnosing DR from fundus images. A combination of morphological image processing and Inception v3 deep learning techniques are exploited to detect DR as well as to classify healthy, mild non-proliferative DR (NPDR), moderate NPDR, severe NPDR, and proliferative DR (PDR). The proposed algorithm was carried out in several steps such as segmentation of blood vessels, localization and removal of optic disc, and macula, abnormal features detection (microaneurysms, hemorrhages, and neovascularization), and classification. Microaneurysms and hemorrhages that appear in the retina are the early signs of DR. In this work, we have detected microaneurysms and hemorrhages by applying dynamic contrast limited adaptive histogram equalization and threshold value on overlapping patched images. An overall accuracy of 96.83% is obtained to classify DR into five different stages. The better performance demonstrates the effectiveness and novelty of the proposed work as compared to the recent reported work.

2.
Front Pharmacol ; 13: 950337, 2022.
Article in English | MEDLINE | ID: mdl-35991897

ABSTRACT

The morbidity and mortality of atherosclerotic cardiovascular disease (ASCVD) is increasing year by year. Cortex Moutan is a traditional Chinese medicinal herb that has been widely used for thousands of years to treat a wide variety of diseases in Eastern countries due to its heat-clearing and detoxifying effects. Paeonol is a bioactive monomer extracted from Cortex Moutan, which has anti-atherosclerotic effects. In this article, we reviewed the pharmacological effects of paeonol against experimental atherosclerosis, as well as its protective effects on vascular endothelial cells, smooth muscle cells, macrophages, platelets, and other important cell types. The pleiotropic effects of paeonol in atherosclerosis suggest that it can be a promising therapeutic agent for atherosclerosis and its complications. Large-scale randomized clinical trials are warranted to elucidate whether paeonol are effective in patients with ASCVD.

3.
J Oncol ; 2022: 8901326, 2022.
Article in English | MEDLINE | ID: mdl-35401745

ABSTRACT

Tumor immune escape has emerged as the most significant barrier to cancer therapy. A thorough understanding of tumor immune escape therapy mechanisms is critical for further improving clinical treatment strategies. Currently, research indicates that combining several immunotherapies can boost antitumor efficacy and encourage T cells to play a more active part in the immune assault. To generate a more substantial therapeutic impact, it can establish an ideal tumor microenvironment (TME), encourage T cells to play a role, prevent T cell immune function reversal, and minimize tumor immune tolerance. In this review, we will examine the mechanisms of tumor immune escape and the limits of tumor immune escape therapy, focusing on the current development of immunotherapy based on tumor immune escape mechanisms. Individualized tumor treatment is becoming increasingly apparent as future treatment strategies. In addition, we forecast the future research direction of cancer and the clinical approach for cancer immunotherapy. It will serve as a better reference for researchers working in cancer therapy research.

4.
Int Urol Nephrol ; 53(8): 1515-1528, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33907984

ABSTRACT

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is the most frequent form of prostatitis, and has a serious impact on patients' quality of life, and causes severe symptoms. The pain in the pelvic, perineal and penile areas, lower abdominal pain, and pain during urination or ejaculation are the main complaints of CP/CPPS. The underlying complex and unknown pathophysiology of this syndrome have made the management of CP/CPPS and the availability of monotherapy challenging. To identify an effective monotherapy, a plethora of clinical trials failed due to its puzzling etiology. Antibiotics, anti-inflammatory, and a-blockers have been commonly used for the treatment of CP/CPPS, but the desired and complete effects have not been gotten yet. The patients and clinicians are attracted to alternative therapies because of their multi-targeted effects. Attention toward natural compounds effectiveness and safety, supporting the development of a new nutraceutical science. In the alternative remedies for the treatment of prostatic diseases, medicinal herbs, in the form of herb parts or extracts, are getting attention due to their positive effects on prostatic diseases. At present, there is no available detailed literature review about the efficacy of medicinal herbs in the treatment of CP/CPPS. This review aimed to explore the useful medicinal herbs in the treatment of CP/CPPS from different perspectives and their possible mechanism of action in managing CP/CPPS.


Subject(s)
Dietary Supplements , Plants, Medicinal , Prostatitis/therapy , Humans , Male
5.
Curr Pharm Des ; 27(25): 2861-2871, 2021.
Article in English | MEDLINE | ID: mdl-33749554

ABSTRACT

Chronic prostatitis/chronic pelvic pain syndrome type III is related to irritative voiding, sexual dysfunction, and pelvic pain. Chronic prostatitis/chronic pelvic pain syndrome weakens the quality of life and poses adverse psychological effects on the patients. A wide range of treatments, including botulinum neurotoxins, anti-inflammatories, alpha-blockers, phytotherapy, 5α-reductase inhibitors, phosphodiesterase type 4 inhibitor, phosphodiesterase type 5 inhibitor, monoclonal antibody, anticholinergics, gabapentin, pregabalin is used clinically. These therapies emphasize easing the symptoms in specific areas without curing the fundamental cause where the outcome of the treatment is not completely satisfactory. This review article explains the recent pharmacological treatments of chronic prostatitis/chronic pelvic pain syndrome in detail and offers a future perspective to treat this condition.


Subject(s)
Acupuncture Therapy , Chronic Pain , Prostatitis , Anti-Inflammatory Agents/therapeutic use , Chronic Disease , Chronic Pain/drug therapy , Humans , Male , Pelvic Pain/drug therapy , Prostatitis/drug therapy , Quality of Life
6.
Andrologia ; 53(1): e13913, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33236398

ABSTRACT

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a frustrating and often debilitating disease. Current studies have shown that Traditional Chinese Medicine (TCM) can improve patients' quality of life and alleviate CP/CPPS symptoms. In this study, the efficacy of Hedyotis diffusa Willd aqueous extraction in experimental autoimmune prostatitis (EAP) mice models was revealed. The C57BL/6 mice were randomly assigned to three groups. Except for the control group, all other groups were subcutaneously injected with 0.2 ml emulsion of T2 peptide, on day 0 and day 14, for inducing EAP models. After the EAP modelling, oral saline was given to the model group, while the H. diffusa group was treated with aqueous extract of H. diffusa Willd. Micturition habits and withdrawal response frequencies were measured. Haematoxylin and eosin staining and immunohistochemistry were used to investigate inflammatory cell infiltration and TNF-α in the prostate tissue respectively. TNF-α levels in the serum were evaluated by ELISA. The H. diffusa Willd aqueous extraction considerably reduced the urine spots number and increased the pain threshold in H. diffusa group. H. diffusa group showed significantly reduced inflammatory lesion and inflammatory cell infiltration than the model group. The levels of TNF-α in H. diffusa group were considerably reduced.


Subject(s)
Hedyotis , Prostatitis , Animals , Humans , Male , Mice , Mice, Inbred C57BL , Pelvic Pain , Prostatitis/drug therapy , Quality of Life
7.
Int J Epidemiol ; 37(2): 397-404, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18276635

ABSTRACT

BACKGROUND: Women remain at increased risk of mortality for some time after pregnancy although the length of this period is unclear. The aim of this study is to examine mortality after pregnancy in rural Bangladesh using data from a unique demographic surveillance system. METHODS: We included all person-time in women aged 15-50 between 1983 and 2001 and compared mortality rates by time since pregnancy outcome (live birth, stillbirth, induced and spontaneous abortion) using Poisson regression, adjusting for socio-demographic factors. RESULTS: Mortality was highest on the first day after pregnancy (adjusted RR compared with third to fourth year post-partum 105.74, 95% CI: 76.08, 146.95) and remained elevated until 180 days (adjusted RR 1.55, 95% CI: 1.13, 2.11). Pregnancies ending in abortions and stillbirths accounted for 50% of deaths in women within 6 weeks of the end of pregnancy, and mortality after these outcomes was between two and four times as high as mortality after a livebirth. CONCLUSION: The high mortality rates immediately after birth provide strong support for a skilled attendance strategy. After abortions or stillbirths, women should be under surveillance for up to 1 week. Further work on the cause of deaths in the late post-partum period is required to understand the mechanisms behind increased mortality risks at these times.


Subject(s)
Developing Countries , Maternal Mortality , Pregnancy Complications/mortality , Abortion, Induced , Abortion, Spontaneous , Adolescent , Adult , Bangladesh , Female , Humans , Maternal Health Services/standards , Postpartum Period , Pregnancy , Pregnancy in Adolescence , Rural Population , Stillbirth
SELECTION OF CITATIONS
SEARCH DETAIL
...